The Goldman Sachs Group Issues Pessimistic Forecast for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CME) had its price target lowered by analysts at The Goldman Sachs Group from $275.00 to $267.00 in a research report issued to clients and investors on Thursday,MarketScreener reports. The firm currently has a “sell” rating on the financial services provider’s stock. The Goldman Sachs Group’s price objective indicates a potential downside of 6.32% from the company’s current price.

A number of other equities research analysts also recently commented on the company. Wall Street Zen upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, April 18th. Argus restated a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Morgan Stanley lifted their target price on CME Group from $340.00 to $362.00 and gave the company an “overweight” rating in a research report on Friday, April 10th. Barclays reduced their target price on CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a research report on Thursday. Finally, JPMorgan Chase & Co. lifted their target price on CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research report on Thursday, April 16th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $306.71.

CME Group Price Performance

NASDAQ:CME opened at $285.02 on Thursday. CME Group has a 52 week low of $257.17 and a 52 week high of $329.16. The company has a quick ratio of 1.03, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $102.22 billion, a P/E ratio of 24.32, a P/E/G ratio of 3.02 and a beta of 0.26. The stock’s fifty day moving average is $304.51 and its two-hundred day moving average is $286.07.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the previous year, the business earned $2.80 earnings per share. The company’s revenue for the quarter was up 14.5% on a year-over-year basis. Equities analysts expect that CME Group will post 12.26 EPS for the current year.

Insider Transactions at CME Group

In other news, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the sale, the director directly owned 43,007 shares of the company’s stock, valued at approximately $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the sale, the general counsel directly owned 7,192 shares of the company’s stock, valued at $2,397,597.04. The trade was a 31.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 8,539 shares of company stock valued at $2,713,821. Corporate insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

A number of institutional investors have recently modified their holdings of the company. Caldwell Trust Co grew its stake in CME Group by 116.3% during the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 50 shares in the last quarter. Asset Dedication LLC grew its stake in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in CME Group during the 3rd quarter worth $27,000. FNY Investment Advisers LLC acquired a new position in CME Group during the 4th quarter worth $27,000. Finally, Elkhorn Partners Limited Partnership acquired a new position in CME Group during the 4th quarter worth $27,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and volumes: CME reported record Q1 revenue and a surge in trading volumes, driven by higher hedging and risk-management activity — a core driver of futures and options trading revenue. Article Title
• Positive Sentiment: Earnings-call commentary backs the volume story: Management emphasized broad-based demand and rising market risk that is increasing hedging flows — a positive outlook for transaction-driven revenue. Article Title Article Title
• Positive Sentiment: Full earnings transcript available for deeper color: Investors can review management’s detail on volume drivers and segment performance. Article Title
• Neutral Sentiment: Multiple analysts trimmed price targets but kept constructive ratings: Deutsche Bank cut its PT to $322 (keeps buy) and TD Cowen cut to $323 (keeps buy); Morgan Stanley trimmed to $353 but retained overweight — these lower targets reflect model updates despite continued positive ratings. Article Title Article Title Article Title
• Neutral Sentiment: No meaningful short-interest signal: the short-interest data published for April is effectively zero/unchanged and does not explain the move. (No linked article.)
• Negative Sentiment: Goldman maintains a sell rating and lowered its PT to $267 — the most bearish big-bank view in the group and a direct negative for sentiment. Article Title
• Negative Sentiment: Mixed market reaction and some headline takes that Q1 sales missed analyst expectations or that the stock looks expensive post-earnings — these narratives can pressure short-term price action despite strong volume trends. Article Title Article Title

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.